{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:19:35Z","timestamp":1790651975423,"version":"4.1.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12883-016-0779-9","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T20:15:36Z","timestamp":1483992936000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Screening for onconeural antibodies in neuromyelitis optica spectrum disorders"],"prefix":"10.1186","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7680-8880","authenticated-orcid":false,"given":"Benjamin","family":"Berger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Hottenrott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Rauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Stich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,10]]},"reference":[{"issue":"10","key":"779_CR1","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66(10):1485\u20139.","journal-title":"Neurology"},{"issue":"5","key":"779_CR2","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","volume":"53","author":"DM Wingerchuk","year":"1999","unstructured":"Wingerchuk DM, Hogancamp WF, O\u2019Brien PC, Weinshenker BG. The clinical course of neuromyelitis optica (Devic\u2019s syndrome). Neurology. 1999;53(5):1107\u201314.","journal-title":"Neurology"},{"issue":"4","key":"779_CR3","volume":"4","author":"F Paul","year":"2007","unstructured":"Paul F, Jarius S, Aktas O, et al. Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica. PLoS One. 2007;4(4), e133.","journal-title":"PLoS One"},{"issue":"2","key":"779_CR4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/cei.12271","volume":"176","author":"S Jarius","year":"2014","unstructured":"Jarius S, Wildemann B, Paul F. Neuromyelitis optica: clinical features, immunopathogenesis and treatment. Clin Exp Immunol. 2014;176(2):149\u201364.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"779_CR5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177\u201389.","journal-title":"Neurology"},{"key":"779_CR6","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/jnnp.2003.034447","volume":"75","author":"F Graus","year":"2004","unstructured":"Graus F, Delattre J, Antoine J, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004;75:1135\u201341.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"779_CR7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/ana.10587","volume":"54","author":"SA Cross","year":"2003","unstructured":"Cross SA, Salomao DR, Parisi JE, et al. Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG. Ann Neurol. 2003;54(1):38\u201350.","journal-title":"Ann Neurol"},{"issue":"3","key":"779_CR8","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/jnnp.2006.097972","volume":"78","author":"F Ducray","year":"2007","unstructured":"Ducray F, Roos-Weil R, Garcia P, et al. Devic\u2019s syndrome-like phenotype associated with thymoma and anti-CV2\/CRMP5 antibodies. J Neurol Neurosurg Psychiatry. 2007;78(3):325\u20137.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"779_CR9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.clineuro.2011.10.048","volume":"114","author":"S Jarius","year":"2012","unstructured":"Jarius S, Wandinger KP, Borowski K, Stoecker W, Wildemann B. Antibodies to CV2\/CRMP5 in neuromyelitis optica-like disease: case report and review of the literature. Clin Neurol Neurosurg. 2012;114(4):331\u20135.","journal-title":"Clin Neurol Neurosurg"},{"issue":"4","key":"779_CR10","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/ana.21324","volume":"63","author":"BM Keegan","year":"2008","unstructured":"Keegan BM, Pittock SJ, Lennon VA. Autoimmune myelopathy associated with collapsin response-mediator protein-5 immunoglobulin G. Ann Neurol. 2008;63(4):531\u20134.","journal-title":"Ann Neurol"},{"issue":"3","key":"779_CR11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.hemonc.2014.06.001","volume":"7","author":"T Al-Harbi","year":"2014","unstructured":"Al-Harbi T, Al-Sarawi A, Binfalah M, Dermime S. Paraneoplastic neuromyelitis optica spectrum disorder associated with stomach carcinoid tumor. Hematol Oncol Stem Cell Ther. 2014;7(3):116\u20139.","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"7","key":"779_CR12","first-page":"660","volume":"126","author":"G Cai","year":"2016","unstructured":"Cai G, He D, Chu L, Dai Q, Xu Z, Zhang Y. Paraneoplastic neuromyelitis optica spectrum disorders: three new cases and a review of the literature. Int J Neurosci. 2016;126(7):660\u20138.","journal-title":"Int J Neurosci"},{"issue":"5","key":"779_CR13","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10072-009-0112-0","volume":"30","author":"G Santis De","year":"2009","unstructured":"De Santis G, Caniatti L, De Vito A, De Gennaro R, Granieri E, Tola MR. A possible paraneoplastic neuromyelitis optica associated with lung cancer. Neurol Sci. 2009;30(5):397\u2013400.","journal-title":"Neurol Sci"},{"key":"779_CR14","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jocn.2015.08.006","volume":"23","author":"K Moussawi","year":"2016","unstructured":"Moussawi K, Lin DJ, Matiello M, Chew S, Morganstern D, Vaitkevicius H. Brainstem and limbic encephalitis with paraneoplastic neuromyelitis optica. J Clin Neurosci. 2016;23:159\u201361.","journal-title":"J Clin Neurosci"},{"issue":"5","key":"779_CR15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/ncpneuro0765","volume":"4","author":"S Mueller","year":"2008","unstructured":"Mueller S, Dubal DB, Josephson SA. A case of paraneoplastic myelopathy associated with the neuromyelitis optica antibody. Nat Clin Pract Neurol. 2008;4(5):284\u20138.","journal-title":"Nat Clin Pract Neurol"},{"issue":"7","key":"779_CR16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3109\/00207454.2013.854208","volume":"124","author":"D Ontaneda","year":"2014","unstructured":"Ontaneda D, Fox R. Is neuromyelitis optica with advanced age of onset a paraneoplastic disorder? Int J Neurosci. 2014;124(7):509\u201311.","journal-title":"Int J Neurosci"},{"issue":"5","key":"779_CR17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/archneur.65.5.629","volume":"65","author":"SJ Pittock","year":"2008","unstructured":"Pittock SJ, Lennon VA. Aquaporin-4 autoantibodies in a paraneoplastic context. Arch Neurol. 2008;65(5):629\u201332.","journal-title":"Arch Neurol"},{"issue":"4","key":"779_CR18","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1179\/2045772312Y.0000000018","volume":"35","author":"H Armagan","year":"2012","unstructured":"Armagan H, T\u00fcz\u00fcn E, Ic\u00f6z O, et al. Long extensive transverse myelitis associated with aquaporin-4 antibody and breast cancer: favorable response to cancer treatment. J Spinal Cord Med. 2012;35(4):267\u20139.","journal-title":"J Spinal Cord Med"},{"issue":"4","key":"779_CR19","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/jamaneurol.2013.6331","volume":"71","author":"M Figueroa","year":"2014","unstructured":"Figueroa M, Guo Y, Tselis A, et al. Paraneoplastic neuromyelitis optica spectrum disorder associated with metastatic carcinoid expressing aquaporin-4. JAMA Neurol. 2014;71(4):495\u20138.","journal-title":"JAMA Neurol"},{"issue":"1-2","key":"779_CR20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jneuroim.2013.07.003","volume":"263","author":"M Frasquet","year":"2013","unstructured":"Frasquet M, Bataller L, Torres-Vega E, et al. Longitudinally extensive transverse myelitis with AQP4 antibodies revealing ovarian teratoma. J Neuroimmunol. 2013;263(1-2):145\u20137.","journal-title":"J Neuroimmunol"},{"issue":"6","key":"779_CR21","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1177\/1352458515572241","volume":"21","author":"R Iorio","year":"2015","unstructured":"Iorio R, Rindi G, Erra C, Damato V, Ferilli M, Sabatelli M. Neuromyelitis optica spectrum disorder as a paraneoplastic manifestation of lung adenocarcinoma expressing aquaporin-4. Mult Scler. 2015;21(6):791\u20134.","journal-title":"Mult Scler"},{"issue":"07","key":"779_CR22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.5414\/NP300855","volume":"34","author":"CVM Verschuur","year":"2015","unstructured":"Verschuur CVM, van der Kooi AJ, Troost D. Anti-aquaporin 4 related paraneoplastic neuromyelitis optica in the presence of adenocarcinoma of the lung. Clin Neuropathol. 2015;34(07):232\u20136.","journal-title":"Clin Neuropathol"},{"key":"779_CR23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1471-2415-14-106","volume":"14","author":"HK Yang","year":"2014","unstructured":"Yang HK, Woo SJ, Park W, Hwang J. Paraneoplastic neuromyelitis optica associated with ANNA-1 antibodies in invasive thymoma. BMC Ophthalmol. 2014;14:106.","journal-title":"BMC Ophthalmol"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-016-0779-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T03:45:17Z","timestamp":1498362317000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-016-0779-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,10]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["779"],"URL":"https:\/\/doi.org\/10.1186\/s12883-016-0779-9","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,10]]},"article-number":"5"}}